A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol

Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) show varying degrees of response to intravenous immunoglobulin (IVIg) therapy. This randomised phase III study in patients with CIDP (ProCID trial) will compare the efficacy and safety of 3 different doses (0.5, 1.0, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornblath, David R., Hartung, Hans‐Peter, Katzberg, Hans D., Merkies, Ingemar S. J., van Doorn, Pieter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2018
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033152/
https://www.ncbi.nlm.nih.gov/pubmed/29603842
http://dx.doi.org/10.1111/jns.12267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033152/
https://www.ncbi.nlm.nih.gov/pubmed/29603842
http://dx.doi.org/10.1111/jns.12267

Ejemplares similares